Literature DB >> 27408114

Percutaneous Closure of Perimembranous Ventricular Septal Defect with Amplatzer Device.

P Bharadwaj1, A Banerji1, R Datta1, H Singh2, A K Ghosh3, G Keshavamurthy4.   

Abstract

BACKGROUND: The Amplatzer perimembranous ventricular septal occluder is an innovative device for percutaneous closure of perimembranous ventricular septal defects (PMVSD). In appropriately selected cases this procedure is safe and effective.
METHODS: Fourteen patients with the mean age 10.53 years (range 18 months to 55 years) and mean body weight 20.64 kg (range 6 to 52 kg) underwent PMVSD closure. RESULT: The PMVSD mean diameter was 5.28 mm (range from 4 to 9 mm). Implantation was successful in 92% of the cases and all patients had complete occlusion of the shunt within three months.
CONCLUSION: Device orientation was excellent in all cases. Device-related aortic insufficiency, tricuspid insufficiency or left ventricular dysfunction was not observed. One patient had embolisation of the device and another had complete heart block which required a permanent pacemaker implantation. The excellent short term results need to be confirmed over long-term follow-up.

Entities:  

Keywords:  Arrhythmias, Percutaneous closure; Perimembranous ventricular septal defect

Year:  2011        PMID: 27408114      PMCID: PMC4921599          DOI: 10.1016/S0377-1237(08)80055-X

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  13 in total

1.  Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations.

Authors:  Z M Hijazi; F Hakim; F Al-Fadley; J Abdelhamid; Q L Cao
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

2.  Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up.

Authors:  G S Kalra; P K Verma; A Dhall; S Singh; R Arora
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

3.  Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.

Authors:  B D Thanopoulos; G S Tsaousis; G N Konstadopoulou; A G Zarayelyan
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

4.  Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.

Authors:  J Masura; P Gavora; A Formanek; Z M Hijazi
Journal:  Cathet Cardiovasc Diagn       Date:  1997-12

5.  Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder.

Authors:  David J Waight; Emile A Bacha; Madelyn Kahana; Qi-Ling Cao; Mary Heitschmidt; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2002-03       Impact factor: 2.692

6.  Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience.

Authors:  Ziyad M Hijazi; Fakhri Hakim; A Abu Haweleh; Awni Madani; Walid Tarawna; Aktham Hiari; Qi-Ling Cao
Journal:  Catheter Cardiovasc Interv       Date:  2002-08       Impact factor: 2.692

7.  Restrictive ventricular septal defect: how small is too small to close?

Authors:  C L Backer; R C Winters; V R Zales; H Takami; A J Muster; D W Benson; C Mavroudis
Journal:  Ann Thorac Surg       Date:  1993-11       Impact factor: 4.330

8.  Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.

Authors:  John L Bass; G S Kalra; Ramesh Arora; Jozef Masura; Pavlo Gavora; Basil D Thanopoulos; William Torres; Horst Sievert; Mario Carminati; Gunther Fischer; Peter Ewert
Journal:  Catheter Cardiovasc Interv       Date:  2003-02       Impact factor: 2.692

9.  Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register.

Authors:  E B Sideris; K P Walsh; J L Haddad; C R Chen; S G Ren; H Kulkarni
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

10.  Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects.

Authors:  L Kidd; D J Driscoll; W M Gersony; C J Hayes; J F Keane; W M O'Fallon; D R Pieroni; R R Wolfe; W H Weidman
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.